Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study

• Published in: Frontiers in medicine Vol. 9; p. 910623
• Main Authors: Tien, Ni, Wu, Tien-Yuan, Lin, Cheng-Li, Wu, Chia-Jui, Hsu, Chung-Y, Fang, Yi-Jen, Lim, Yun-Ping
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 13.06.2022
• Subjects: hyperlipidemia; IBD medications; inflammatory bowel disease (IBD); lipogenesis; Longitudinal Health Insurance Database (LHID); Medicine

Patients with inflammatory bowel disease (IBD) present a higher risk of developing cardiovascular diseases (CVDs) due to chronic inflammation, which plays an essential role in atherogenesis. Hyperlipidemia is another risk factor for CVDs; however, the association between IBD, IBD medications, and hy...